{"DataElement":{"publicId":"10672197","version":"1","preferredName":"Union for International Cancer Control Staging System Pathologic Primary Tumor TNM Finding Category","preferredDefinition":"The response indicating the pathological stage of the primary tumor using the Union for International Cancer Control staging system as a basis for evaluation of the disease.","longName":"10544804v1.00:10544816v1.00","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"10544804","version":"1","preferredName":"Union for International Cancer Control Staging System Pathologic Primary Tumor TNM Finding","preferredDefinition":"_The International Union Against Cancer (UICC) is the only global cancer organisation with members and activities covering all aspects of cancer control. Founded in 1933, UICC is an independent, international, non-governmental association of 291 member cancer fighting organizations in 87 countries. Located in Geneva, Switzerland._A system for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment:A pathologic finding about one or more characteristics of a specific cancer, following the rules of the TNM classification system as they pertain to staging of the primary tumor.","longName":"2404687v1.00:10544803v1.00","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"10544794","version":"1","preferredName":"International Union Against Cancer TNM Staging System","preferredDefinition":"The International Union Against Cancer (UICC) is the only global cancer organisation with members and activities covering all aspects of cancer control. Founded in 1933, UICC is an independent, international, non-governmental association of 291 member cancer fighting organizations in 87 countries. Located in Geneva, Switzerland._A system for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment.","longName":"C39434:C25384","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Union for International Cancer Control","conceptCode":"C39434","definition":"A global cancer organisation comprising over 1200 organisations in 172 countries with activities covering all aspects of cancer control. It was founded in 1933 as the International Union Against Cancer. The organisation is dedicated to taking the lead in convening, capacity building and advocacy initiatives that unite and support the cancer community to reduce the global cancer burden, promote greater equity, and to ensure cancer control continues to be a priority in the world health and development agenda.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"TNM Staging System","conceptCode":"C25384","definition":"A system for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26DC616-3514-67B5-E053-731AD00AD545","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"10544808","version":"1","preferredName":"Pathologic Primary Tumor TNM Finding","preferredDefinition":"A pathologic finding about one or more characteristics of a specific cancer, following the rules of the TNM classification system as they pertain to staging of the primary tumor.","longName":"C48888","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Primary Tumor TNM Finding","conceptCode":"C48888","definition":"A pathologic finding about one or more characteristics of a specific cancer, following the rules of the TNM classification system as they pertain to evaluating the primary tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2763C89-3DC4-66F9-E053-731AD00A305B","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"UICC Based:Staging Criteria Based on Union for International Cancer Control","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2763C89-3DC1-66F9-E053-731AD00A305B","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":"07.22.22_Curated to support UICC data capture_ghd","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"10544816","version":"1","preferredName":"Pathologic Primary Tumor TNM Finding Category","preferredDefinition":"A pathologic finding about one or more characteristics of a specific cancer, following the rules of the TNM classification system as they pertain to staging of the primary tumor._A grouping of items based on some commonality or by user defined characteristics.","longName":"10544816v1.00","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T0","valueDescription":null,"ValueMeaning":{"publicId":"3201423","version":"1","preferredName":"T0 Stage Finding","longName":"3201423","preferredDefinition":"A primary tumor TNM finding indicating that there is no evidence of primary tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T0 TNM Finding","conceptCode":"C48719","definition":"A primary tumor TNM finding indicating that there is no evidence of primary tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3C0F-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"ONEDATA","dateModified":"2011-03-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-352E-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T1","valueDescription":null,"ValueMeaning":{"publicId":"3687408","version":"1","preferredName":"T1 Stage Finding","longName":"3687408","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1 TNM Finding","conceptCode":"C48720","definition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5CA35AA-9F9B-FFA5-E040-BB89AD435F4C","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"PATELV","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-352F-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T1a","valueDescription":null,"ValueMeaning":{"publicId":"3201425","version":"1","preferredName":"T1a Stage Finding","longName":"3201425","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 0.1cm, but not more than 0.5 cm in greatest dimension; for kidney cancer it refers to a primary tumor that is 4 cm or less in greatest dimension; and for thyroid cancer it refers to a primary tumor that is 1 cm or less in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1a TNM Finding","conceptCode":"C48721","definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 0.1cm, but not more than 0.5 cm in greatest dimension; for kidney cancer it refers to a primary tumor that is 4 cm or less in greatest dimension; and for thyroid cancer it refers to a primary tumor that is 1 cm or less in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3C57-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3530-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T1b","valueDescription":null,"ValueMeaning":{"publicId":"3201426","version":"1","preferredName":"T1b Stage Finding","longName":"3201426","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 0.5 cm, but not more than 1.0 cm in greatest dimension; for kidney cancer it refers to a primary tumor that is more than 4 cm, but not more than 7 cm in greatest dimension; and for thyroid cancer it refers to a primary tumor that is more than 1 cm but not more than 2 cm in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1b TNM Finding","conceptCode":"C48722","definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 0.5 cm, but not more than 1.0 cm in greatest dimension; for kidney cancer it refers to a primary tumor that is more than 4 cm, but not more than 7 cm in greatest dimension; and for thyroid cancer it refers to a primary tumor that is more than 1 cm but not more than 2 cm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3C7C-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3531-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T2c","valueDescription":null,"ValueMeaning":{"publicId":"3201432","version":"1","preferredName":"T2c Stage Finding","longName":"3201432","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2c TNM finding depends on the specific type of cancer that it refers to; for example, for prostate cancer it refers to a primary tumor that involves both lobes of the prostate gland; for ovarian cancer it refers to a primary tumor that involves one or both ovaries with extension or implants on the uterus and/or fallopian tubes, or other pelvic tissues, with malignant cells in either ascites or peritoneal washings; for fallopian tube cancer it refers to a primary tumor with pelvic extension and malignant cells in ascites or peritoneal washings.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T2c TNM Finding","conceptCode":"C48727","definition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2c TNM finding depends on the specific type of cancer that it refers to; for example, for prostate cancer it refers to a primary tumor that involves both lobes of the prostate gland; for ovarian cancer it refers to a primary tumor that involves one or both ovaries with extension or implants on the uterus and/or fallopian tubes, or other pelvic tissues, with malignant cells in either ascites or peritoneal washings; for fallopian tube cancer it refers to a primary tumor with pelvic extension and malignant cells in ascites or peritoneal washings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3D58-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3532-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T1c","valueDescription":null,"ValueMeaning":{"publicId":"3201427","version":"1","preferredName":"T1c Stage Finding","longName":"3201427","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 1.0 cm, but not more than 2.0 cm in greatest dimension; for uterine corpus cancer it refers to a primary tumor that invades one-half or more of the myometrium; and for melanoma of the iris it refers to a primary tumor limited to the iris with secondary glaucoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1c TNM Finding","conceptCode":"C48723","definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth.  The definition of T1c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that is more than 1.0 cm, but not more than 2.0 cm in greatest dimension; for uterine corpus cancer it refers to a primary tumor that invades one-half or more of the myometrium; and for melanoma of the iris it refers to a primary tumor limited to the iris with secondary glaucoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3CA1-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3533-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T1mi","valueDescription":null,"ValueMeaning":{"publicId":"3201428","version":"1","preferredName":"T1mi Stage Finding","longName":"3201428","preferredDefinition":"A term that refers to a TNM finding of a primary tumor limited to the site of growth and indicates microinvasion only.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1mi TNM Finding","conceptCode":"C95805","definition":"A term that refers to a TNM finding of a primary tumor limited to the site of growth and indicates microinvasion only.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3CC6-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3534-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T2","valueDescription":null,"ValueMeaning":{"publicId":"3905891","version":"1","preferredName":"T2 Stage Finding","longName":"3905891","preferredDefinition":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T2 TNM Finding","conceptCode":"C48724","definition":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6D2DE7A-D155-19F1-E040-BB89AD433187","latestVersionIndicator":"Yes","beginDate":"2013-09-20","endDate":null,"createdBy":"PATELV","dateCreated":"2013-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3535-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T2a","valueDescription":null,"ValueMeaning":{"publicId":"3201430","version":"1","preferredName":"T2a Stage Finding","longName":"3201430","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2a TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that measures more than 7 cm but less than or equal to 10 cm in greatest dimension, and is limited to the kidney; for bladder cancer it refers to a primary tumor that invades the superficial muscularis propria (inner half); for cervical cancer it refers to a primary tumor that invades beyond the uterus but not to the pelvic wall or to the lower third of vagina and there is no parametrial invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T2a TNM Finding","conceptCode":"C48725","definition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2a TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that measures more than 7 cm but less than or equal to 10 cm in greatest dimension, and is limited to the kidney; for bladder cancer it refers to a primary tumor that invades the superficial muscularis propria (inner half); for cervical cancer it refers to a primary tumor that invades beyond the uterus but not to the pelvic wall or to the lower third of vagina and there is no parametrial invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3D0E-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3536-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T2b","valueDescription":null,"ValueMeaning":{"publicId":"3201431","version":"1","preferredName":"T2b Stage Finding","longName":"3201431","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2b TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that measures more than 10 cm in greatest dimension, and  is limited to the kidney; for bladder cancer it refers to a primary tumor that invades the deep muscularis propria (outer half); for cervical cancer it refers to a primary tumor that invades beyond the uterus but not to the pelvic wall or to the lower third of vagina and there is parametrial invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T2b TNM Finding","conceptCode":"C48726","definition":"A general term that refers to a TNM finding of a primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2b TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that measures more than 10 cm in greatest dimension, and is limited to the kidney; for bladder cancer it refers to a primary tumor that invades the deep muscularis propria (outer half); for cervical cancer it refers to a primary tumor that invades beyond the uterus but not to the pelvic wall or to the lower third of vagina and there is parametrial invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3D33-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3537-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T2d","valueDescription":null,"ValueMeaning":{"publicId":"10544821","version":"1","preferredName":"T2d Stage Finding","longName":"10544821v1.00","preferredDefinition":"A TNM stage finding term that refers to choroidal and ciliary body melanoma or conjunctival melanoma TNM staging. For choroidal and ciliary body melanoma it means tumor size category 2 with ciliary body involvement and extraocular extension 5 mm or less in largest diameter. For conjunctival melanoma it means caruncular tumor, and more than 1 quadrant of the nonbulbar conjunctiva involved. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T2d TNM Finding","conceptCode":"C148411","definition":"A TNM stage finding term that refers to choroidal and ciliary body melanoma or conjunctival melanoma TNM staging. For choroidal and ciliary body melanoma it means tumor size category 2 with ciliary body involvement and extraocular extension 5 mm or less in largest diameter. For conjunctival melanoma it means caruncular tumor, and more than 1 quadrant of the nonbulbar conjunctiva involved. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26DC616-3538-67B5-E053-731AD00AD545","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-353A-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T3","valueDescription":null,"ValueMeaning":{"publicId":"3201433","version":"1","preferredName":"T3 Stage Finding","longName":"3201433","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T3 TNM Finding","conceptCode":"C48728","definition":"A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3D7B-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-353B-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T3a","valueDescription":null,"ValueMeaning":{"publicId":"5505178","version":"1","preferredName":"T3a Stage Finding","longName":"5505178","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3a TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the renal vein or its segmental (muscle containing) branches or the tumor invades perirenal and/or renal sinus fat but does not extends beyond Gerota's fascia; for cervical cancer it refers to a primary tumor that involves the lower third of vagina, without extension to pelvic wall; for liver cancer it refers to the presence of multiple tumors measuring more than 5 cm in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T3a TNM Finding","conceptCode":"C48729","definition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3a TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the renal vein or its segmental (muscle containing) branches or the tumor invades perirenal and/or renal sinus fat but does not extends beyond Gerota's fascia; for cervical cancer it refers to a primary tumor that involves the lower third of vagina, without extension to pelvic wall; for liver cancer it refers to the presence of multiple tumors measuring more than 5 cm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E1D797B-97AE-2F02-E053-F662850A52CE","latestVersionIndicator":"Yes","beginDate":"2016-10-05","endDate":null,"createdBy":"MORENOC","dateCreated":"2016-10-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-353C-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T3b","valueDescription":null,"ValueMeaning":{"publicId":"5505179","version":"1","preferredName":"T3b Stage Finding","longName":"5505179","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3b TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the vena cava below the diaphragm; for cervical cancer it refers to a primary tumor that extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney; for liver cancer it refers to a single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T3b TNM Finding","conceptCode":"C48730","definition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3b TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the vena cava below the diaphragm; for cervical cancer it refers to a primary tumor that extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney; for liver cancer it refers to a single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E1D797B-97D4-2F02-E053-F662850A52CE","latestVersionIndicator":"Yes","beginDate":"2016-10-05","endDate":null,"createdBy":"MORENOC","dateCreated":"2016-10-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-353D-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T3c","valueDescription":null,"ValueMeaning":{"publicId":"3201436","version":"1","preferredName":"T3c Stage Finding","longName":"3201436","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3c TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the vena cava above the diaphragm, or invades the wall of the vena cava; for fallopian tube cancer it refers to a primary tumor with peritoneal metastasis outside the pelvis measuring more than 2 cm in diameter; for melanoma of the conjunctiva it refers to a primary tumor invading the orbit.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T3c TNM Finding","conceptCode":"C48731","definition":"A general term that refers to a TNM finding of a primary tumor usually indicating that the cancer is locally invasive. The definition of T3c TNM finding depends on the specific type of cancer that it refers to; for example, for kidney cancer it refers to a primary tumor that grossly extends into the vena cava above the diaphragm, or invades the wall of the vena cava; for fallopian tube cancer it refers to a primary tumor with peritoneal metastasis outside the pelvis measuring more than 2 cm in diameter; for melanoma of the conjunctiva it refers to a primary tumor invading the orbit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3DEA-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-353E-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T3d","valueDescription":null,"ValueMeaning":{"publicId":"10544822","version":"1","preferredName":"T3d Stage Finding","longName":"10544822v1.00","preferredDefinition":"A TNM stage finding term that refers to choroidal and ciliary body melanoma, conjunctival melanoma, or retinoblastoma TNM staging. For choroidal and ciliary body melanoma it means tumor size category 3 with ciliary body involvement and extraocular extension 5 mm or less in largest diameter. For conjunctival melanoma it means tumor of any size invading the nasolacrimal duct and/or lacrimal sac and/or paranasal sinuses. For retinoblastoma it means hyphema and/or massive vitreous hemorrhage (clinical) or full-thickness invasion into the outer third of the sclera and/or invasion into or around emissary channels (pathologic). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T3d TNM Finding","conceptCode":"C148412","definition":"A TNM finding term that refers to choroidal and ciliary body melanoma, conjunctival melanoma, or retinoblastoma TNM staging. For choroidal and ciliary body melanoma it means tumor size category 3 with ciliary body involvement and extraocular extension 5 mm or less in largest diameter. For conjunctival melanoma it means tumor of any size invading the nasolacrimal duct and/or lacrimal sac and/or paranasal sinuses. For retinoblastoma it means hyphema and/or massive vitreous hemorrhage (clinical) or full-thickness invasion into the outer third of the sclera and/or invasion into or around emissary channels (pathologic). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26DC616-3539-67B5-E053-731AD00AD545","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-353F-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T4","valueDescription":null,"ValueMeaning":{"publicId":"3201437","version":"1","preferredName":"T4 Stage Finding","longName":"3201437","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4 TNM Finding","conceptCode":"C48732","definition":"A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3E0D-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3540-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T4a","valueDescription":null,"ValueMeaning":{"publicId":"3371635","version":"1","preferredName":"T4a Stage Finding","longName":"3371635","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4a TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the prostatic stroma, uterus, and vagina; for gastric cancer it refers to a primary tumor that invades the serosa (visceral peritoneum); for colorectal cancer it refers to a primary tumor that penetrates to the surface of the visceral peritoneum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4a TNM Finding","conceptCode":"C48733","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4a TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the prostatic stroma, uterus, and vagina; for gastric cancer it refers to a primary tumor that invades the serosa (visceral peritoneum); for colorectal cancer it refers to a primary tumor that penetrates to the surface of the visceral peritoneum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B86257A8-C9CF-3BD6-E040-BB89AD43018B","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"PATELV","dateCreated":"2012-02-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3541-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T4b","valueDescription":null,"ValueMeaning":{"publicId":"3371636","version":"1","preferredName":"T4b Stage Finding","longName":"3371636","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4b TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the pelvic wall and abdominal wall; for gastric cancer it refers to a primary tumor that invades adjacent structures; for colorectal cancer it refers to a primary tumor with direct invasion or adherence to other organs or structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4b TNM Finding","conceptCode":"C48734","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4b TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the pelvic wall and abdominal wall; for gastric cancer it refers to a primary tumor that invades adjacent structures; for colorectal cancer it refers to a primary tumor with direct invasion or adherence to other organs or structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B86257A8-C9F2-3BD6-E040-BB89AD43018B","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"PATELV","dateCreated":"2012-02-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3542-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T4c","valueDescription":null,"ValueMeaning":{"publicId":"3201440","version":"1","preferredName":"T4c Stage Finding","longName":"3201440","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that extends to the chest wall, not including the pectoralis muscle, and with edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast; for ocular adnexal lymphoma it refers to a primary tumor that Involves the maxillofacial, ethmoidal, and/or frontal sinuses; for carcinoma of the conjunctiva it refers to a primary tumor that invades adjacent paranasal sinuses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4c TNM Finding","conceptCode":"C48735","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that extends to the chest wall, not including the pectoralis muscle, and with edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast; for ocular adnexal lymphoma it refers to a primary tumor that Involves the maxillofacial, ethmoidal, and/or frontal sinuses; for carcinoma of the conjunctiva it refers to a primary tumor that invades adjacent paranasal sinuses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3E7C-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3543-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T4d","valueDescription":null,"ValueMeaning":{"publicId":"3201441","version":"1","preferredName":"T4d Stage Finding","longName":"3201441","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4d TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that meets the clinical-pathologic criteria of inflammatory carcinoma; for ocular adnexal lymphoma it refers to a primary tumor with intracranial spread; for carcinoma of the conjunctiva it refers to a primary tumor that invades the brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4d TNM Finding","conceptCode":"C48736","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4d TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that meets the clinical-pathologic criteria of inflammatory carcinoma; for ocular adnexal lymphoma it refers to a primary tumor with intracranial spread; for carcinoma of the conjunctiva it refers to a primary tumor that invades the brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3EA1-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3547-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"TX","valueDescription":null,"ValueMeaning":{"publicId":"3201443","version":"1","preferredName":"TX Stage Finding","longName":"3201443","preferredDefinition":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TX TNM Finding","conceptCode":"C48737","definition":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3EE7-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3548-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"Ta","valueDescription":null,"ValueMeaning":{"publicId":"3205588","version":"1","preferredName":"Ta Stage Finding","longName":"3205588","preferredDefinition":"A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pTa TNM Finding","conceptCode":"C96025","definition":"A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9EC6B910-A661-E8D4-E040-BB89AD43022D","latestVersionIndicator":"Yes","beginDate":"2011-03-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3549-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"Tis","valueDescription":null,"ValueMeaning":{"publicId":"3201442","version":"1","preferredName":"Breast Cancer pTis TNM Finding v6 and v7","longName":"3201442v1.00","preferredDefinition":"Breast cancer with a finding of carcinoma in situ. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pTis TNM Finding v6 and v7","conceptCode":"C48974","definition":"Breast cancer with a finding of carcinoma in situ. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3EC4-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"MMADDINENI","dateModified":"2023-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-354A-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"Tis (DCIS)","valueDescription":null,"ValueMeaning":{"publicId":"10544823","version":"1","preferredName":"Breast Ductal Carcinoma In Situ Tis Stage Finding","longName":"10544823v1.00","preferredDefinition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS._A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"pTis TNM Finding","conceptCode":"C48738","definition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26DC616-3544-67B5-E053-731AD00AD545","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-354B-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"Tis (LCIS)","valueDescription":null,"ValueMeaning":{"publicId":"10544824","version":"1","preferredName":"Breast Lobular Carcinoma In Situ Tis Stage Finding","longName":"10544824v1.00","preferredDefinition":"A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma._A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Lobular Carcinoma In Situ","conceptCode":"C4018","definition":"A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"pTis TNM Finding","conceptCode":"C48738","definition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26DC616-3545-67B5-E053-731AD00AD545","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-354C-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"Tis (Paget's)","valueDescription":null,"ValueMeaning":{"publicId":"10544825","version":"1","preferredName":"Paget Disease Tis Stage Finding","longName":"10544825v1.00","preferredDefinition":"A malignant neoplasm composed of large cells with large nuclei, prominent nucleoli, and abundant pale cytoplasm (Paget cells).  Paget cell neoplasms include Paget disease of the nipple and extramammary Paget disease which may affect the vulva, penis, anus, skin and scrotum._A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Paget Disease","conceptCode":"C7073","definition":"A malignant neoplasm composed of large cells with large nuclei, prominent nucleoli, and abundant pale cytoplasm (Paget cells).  Paget cell neoplasms include Paget disease of the nipple and extramammary Paget disease which may affect the vulva, penis, anus, skin and scrotum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"pTis TNM Finding","conceptCode":"C48738","definition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26DC616-3546-67B5-E053-731AD00AD545","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-354D-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-354E-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-354F-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"T1a1","valueDescription":null,"ValueMeaning":{"publicId":"10672182","version":"1","preferredName":"T1a1 Stage Finding","longName":"10672182v1.00","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth. The definition of T1a1 TNM finding depends on the specific type of cancer to which it refers: for example, for cervical carcinoma it indicates measured stromal invasion equal or less than 3 mm in depth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1a1 Stage Finding","conceptCode":"C188292","definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth. The definition of T1a1 TNM finding depends on the specific type of cancer to which it refers: for example, for cervical carcinoma it indicates measured stromal invasion equal or less than 3 mm in depth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4447DBF-BE4A-7356-E053-731AD00A400C","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E4447DBF-BE4C-7356-E053-731AD00A400C","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"T1a2","valueDescription":null,"ValueMeaning":{"publicId":"10672183","version":"1","preferredName":"T1a2 Stage Finding","longName":"10672183v1.00","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth. The definition of T1a2 TNM finding depends on the specific type of cancer to which it refers: for example, for cervical carcinoma it indicates measured stromal invasion of more than 3.0 mm and equal or less than 5.0 mm in depth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1a2 Stage Finding","conceptCode":"C188293","definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth. The definition of T1a2 TNM finding depends on the specific type of cancer to which it refers: for example, for cervical carcinoma it indicates measured stromal invasion of more than 3.0 mm and equal or less than 5.0 mm in depth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4447DBF-BE4B-7356-E053-731AD00A400C","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E4447DBF-BE4D-7356-E053-731AD00A400C","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"T1b1","valueDescription":null,"ValueMeaning":{"publicId":"10672184","version":"1","preferredName":"T1b1 Stage Finding","longName":"10672184v1.00","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth. The definition of T1b1 TNM finding depends on the specific type of cancer to which it refers: for example, for cervical carcinoma it indicates measured stromal invasion measuring more than 5 mm in depth and equal or less than 2 cm in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1b1 TNM Finding","conceptCode":"C188294","definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth. The definition of T1b1 TNM finding depends on the specific type of cancer to which it refers: for example, for cervical carcinoma it indicates measured stromal invasion measuring more than 5 mm in depth and equal or less than 2 cm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4448D77-1ED0-7511-E053-731AD00A152C","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E4448D77-1ED5-7511-E053-731AD00A152C","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"T1b2","valueDescription":null,"ValueMeaning":{"publicId":"10672185","version":"1","preferredName":"T1b2 Stage Finding","longName":"10672185v1.00","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth. The definition of T1b2 TNM finding depends on the specific type of cancer to which it refers: for example, for cervical carcinoma it indicates stromal invasion measuring more than 2 cm and equal or less than 4 cm in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1b2 TNM Finding","conceptCode":"C188295","definition":"A general term that refers to a TNM finding of a primary tumor limited to the site of growth. The definition of T1b2 TNM finding depends on the specific type of cancer to which it refers: for example, for cervical carcinoma it indicates stromal invasion measuring more than 2 cm and equal or less than 4 cm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4448D77-1ED1-7511-E053-731AD00A152C","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E4448D77-1ED6-7511-E053-731AD00A152C","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"T2a1","valueDescription":null,"ValueMeaning":{"publicId":"10672186","version":"1","preferredName":"T2a1 Stage Finding","longName":"10672186v1.00","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T2a1 TNM finding depends on the specific type of cancer to which it refers: for example, for cervical carcinoma it indicates involvement limited to the upper two-thirds of the vagina without parametrial invasion measuring 4.0 cm or less in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T2a1 TNM Finding","conceptCode":"C188296","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T2a1 TNM finding depends on the specific type of cancer to which it refers: for example, for cervical carcinoma it indicates involvement limited to the upper two-thirds of the vagina without parametrial invasion measuring 4.0 cm or less in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4448D77-1ED2-7511-E053-731AD00A152C","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E4448D77-1ED7-7511-E053-731AD00A152C","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"T2a2","valueDescription":null,"ValueMeaning":{"publicId":"10672187","version":"1","preferredName":"T2a2 Stage Finding","longName":"10672187v1.00","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T2a2 TNM finding depends on the specific type of cancer to which it refers: for example, for cervical carcinoma it indicates involvement limited to the upper two-thirds of the vagina without parametrial invasion measuring more than 4.0 cm in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T2a2 TNM Finding","conceptCode":"C188297","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T2a2 TNM finding depends on the specific type of cancer to which it refers: for example, for cervical carcinoma it indicates involvement limited to the upper two-thirds of the vagina without parametrial invasion measuring more than 4.0 cm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4448D77-1ED3-7511-E053-731AD00A152C","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E4448D77-1ED8-7511-E053-731AD00A152C","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"T4e","valueDescription":null,"ValueMeaning":{"publicId":"10672188","version":"1","preferredName":"M1d Stage Finding","longName":"10672188v1.00","preferredDefinition":"A TNM finding indicating the spread of cancer to distant anatomic sites. The definition of M1d TNM finding depends on the specific type of cancer to which it refers: for example, for cutaneous melanoma it indicates distant metastasis to CNS with or without M1a, M1b, or M1c sites of disease. LDH level not recorded or unspecified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"M1d TNM Finding","conceptCode":"C188301","definition":"A TNM finding indicating the spread of cancer to distant anatomic sites. The definition of M1d TNM finding depends on the specific type of cancer to which it refers: for example, for cutaneous melanoma it indicates distant metastasis to CNS with or without M1a, M1b, or M1c sites of disease. LDH level not recorded or unspecified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4448D77-1ED4-7511-E053-731AD00A152C","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E4448D77-1ED9-7511-E053-731AD00A152C","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"10544815","version":"1","preferredName":"Pathologic Primary Tumor TNM Finding Category","preferredDefinition":"A pathologic finding about one or more characteristics of a specific cancer, following the rules of the TNM classification system as they pertain to staging of the primary tumor._A grouping of items based on some commonality or by user defined characteristics.","longName":"10544815v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Primary Tumor TNM Finding","conceptCode":"C48888","definition":"A pathologic finding about one or more characteristics of a specific cancer, following the rules of the TNM classification system as they pertain to evaluating the primary tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26DC616-3528-67B5-E053-731AD00AD545","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"UICC Based:Staging Criteria Based on Union for International Cancer Control","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26DC616-3529-67B5-E053-731AD00AD545","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":"07.22.22_Curated to support UICC data_ghd","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"UICC Pathological T Stage","url":null,"context":"OCG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4453E2A-7B77-11C7-E053-731AD00AB62E","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":"07.22.22_Curated to support UICC data capture_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}